VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+5.45%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$243M
AUM Growth
+$6.44M
(+2.7%)
Cap. Flow
-$3.44M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
7.68%
Holding
410
New
55
Increased
156
Reduced
186
Closed
11
Top Buys
| 1 |
BKCC
BlackRock Capital Investment Corporation
BKCC
|
$670K |
| 2 |
Zai Lab
ZLAB
|
$520K |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$422K |
| 4 |
DRD
DRDGold
DRD
|
$405K |
| 5 |
Stellus Capital Investment Corp
SCM
|
$402K |
Top Sells
| 1 |
AMRS
Amyris Inc.
AMRS
|
$1.28M |
| 2 |
Prothena Corp
PRTA
|
$971K |
| 3 |
BioNTech
BNTX
|
$787K |
| 4 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
$647K |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$645K |
Sector Composition
| 1 | Healthcare | 27.38% |
| 2 | Real Estate | 18.81% |
| 3 | Energy | 13.29% |
| 4 | Materials | 10.7% |
| 5 | Utilities | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Aprea Therapeutics
APRE
$8.8M
| – | – |
-523
| Closed | -$53K |
|
402
Kezar Life Sciences
KZR
$28.2M
| – | – |
-5,431
| Closed | -$324K |
|
403
NextCure
NXTC
$13.3M
| – | – |
-2,035
| Closed | -$244K |
|
404
Voyager Therapeutics
VYGR
$206M
| – | – |
-35,712
| Closed | -$168K |
|
|
OYST
405
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| – | – |
-14,995
| Closed | -$274K |
|
|
CALA
406
DELISTED
Calithera Biosciences, Inc
CALA
| – | – |
-3,058
| Closed | -$148K |
|
|
ODT
407
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| – | – |
-19,421
| Closed | -$66K |
|
|
CNST
408
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – |
-9,500
| Closed | -$222K |
|
|
EFF
409
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
| – | – |
-17,104
| Closed | -$278K |
|
|
FPRX
410
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – |
-17,112
| Closed | -$645K |
|